Stocks and Investing Stocks and Investing
Wed, February 15, 2023

Swayampakula Ramakanth Reiterated (BCYC) at Strong Buy and Held Target at $57 on, Feb 15th, 2023


Published on 2024-10-28 01:38:15 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Reiterated "Bicycle Therapeutics plc" (BCYC) at Strong Buy and Held Target at $57 on, Feb 15th, 2023.

Swayampakula has made no other calls on BCYC in the last 4 months.



There is 1 other peer that has a rating on BCYC. Out of the 1 peers that are also analyzing BCYC, 0 agree with Swayampakula's Rating of Hold.



This is the rating of the analyst that currently disagrees with Swayampakula


  • Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Wednesday, November 9th, 2022

Contributing Sources